Level Zero Health, a female-founded medical device startup that’s aiming to break new ground by developing a device for continuous hormone monitoring, has closed an oversubscribed $6.9 million pre-seed funding round despite being only a little over a year old. The startup wants to do away with the need for invasive blood draws and support […] © 2024 TechCrunch. All rights reserved. For personal use only.
Level Zero Health, a female-founded medical device startup, has secured $6.9 million in a pre-seed funding round to develop a wearable device for continuous hormone monitoring. The device uses tiny needles to sample hormones under the skin, aiming to eliminate invasive blood draws. The technology could support research into hormone-related conditions and pave the way for personalized treatments, such as individualized hormone-based contraception. The startup plans to launch a single-use prototype for specific medical cases, like fertility treatments, before targeting a continuous monitoring device for 2028. The company is pursuing regulatory approvals and exploring a B2B business model to sell their technology to healthcare providers. Investors are optimistic about the technology's potential, likening it to the impact of continuous glucose monitors in diabetes care. The funding was led by European VC Redalpine.